Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis
Clinical trial NCT03401229 · COMPLETED
Trial details
- NCT number
- NCT03401229
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2020-07-31
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.